FR11C0014I2 - Clones d'adn infectieux chimeres de circovirus porcin et utilisation de ceux-ci - Google Patents

Clones d'adn infectieux chimeres de circovirus porcin et utilisation de ceux-ci

Info

Publication number: FR11C0014I2
Authority: FR; France
Prior art keywords: porcine circovirus; dna clones; infectious dna; chimeric infectious; chimeric
Prior art date: 2001-12-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR11C0014C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Virginia Tech Intellectual Properties Inc

Iowa State University Research Foundation Inc ISURF

Original Assignee

Virginia Tech Intellectual Properties Inc

Iowa State University Research Foundation Inc ISURF

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-12

Filing date

2011-05-03

Publication date

2022-03-11

2011-05-03 Application filed by Virginia Tech Intellectual Properties Inc, Iowa State University Research Foundation Inc ISURF filed Critical Virginia Tech Intellectual Properties Inc

2011-06-17 Publication of FR11C0014I1 publication Critical patent/FR11C0014I1/fr

2022-03-11 Application granted granted Critical

2022-03-11 Publication of FR11C0014I2 publication Critical patent/FR11C0014I2/fr

Status Active legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10061—Methods of inactivation or attenuation

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Microbiology (AREA)
Biophysics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

FR11C0014C 2001-12-12 2011-05-03 Clones d'adn infectieux chimeres de circovirus porcin et utilisation de ceux-ci Active FR11C0014I2 (fr)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US34077501P	2001-12-12	2001-12-12
US42484002P	2002-11-08	2002-11-08
US10/314,512 US7276353B2 (en)	2001-12-12	2002-12-09	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
PCT/US2002/039646 WO2003049703A2 (fr)	2001-12-12	2002-12-11	Clones d'adn infectieux chimeres, circovirus porcins chimeres et utilisation de ceux-ci

Publications (2)

Publication Number	Publication Date
FR11C0014I1 FR11C0014I1 (fr)	2011-06-17
FR11C0014I2 true FR11C0014I2 (fr)	2022-03-11

Family

ID=27405726

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR11C0014C Active FR11C0014I2 (fr)	2001-12-12	2011-05-03	Clones d'adn infectieux chimeres de circovirus porcin et utilisation de ceux-ci

Country Status (30)

Country	Link
US (1)	US7276353B2 (fr)
EP (5)	EP2264050B1 (fr)
JP (1)	JP4623964B2 (fr)
KR (1)	KR101014544B1 (fr)
CN (2)	CN103536911B (fr)
AT (1)	ATE487490T1 (fr)
AU (3)	AU2002362147C1 (fr)
BE (1)	BE2011C008I2 (fr)
BR (1)	BRPI0214919B1 (fr)
CA (2)	CA2784260C (fr)
CO (1)	CO5590938A2 (fr)
CY (3)	CY1111167T1 (fr)
DE (2)	DE60238278D1 (fr)
DK (3)	DK1487483T3 (fr)
ES (3)	ES2355814T3 (fr)
FR (1)	FR11C0014I2 (fr)
HR (3)	HRP20040626B9 (fr)
HU (5)	HU231018B1 (fr)
LT (1)	LT2264050T (fr)
LU (1)	LU91814I2 (fr)
ME (1)	ME00126B (fr)
MX (1)	MXPA04005364A (fr)
NL (1)	NL300480I2 (fr)
NZ (2)	NZ567688A (fr)
PL (3)	PL395510A1 (fr)
PT (3)	PT1487483E (fr)
RS (1)	RS51288B (fr)
SI (3)	SI1487483T1 (fr)
TW (1)	TWI314580B (fr)
WO (1)	WO2003049703A2 (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2772047B1 (fr) *	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
US7279166B2 (en)	2001-12-12	2007-10-09	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
CN1749397B (zh) *	2004-08-18	2010-12-08	金宁一	共表达猪圆环病毒及口蹄疫病毒的二联重组活载体疫苗
PT2460817T (pt)	2004-12-30	2017-07-03	Boehringer Ingelheim Vetmedica Inc	Composições imunogénicas de pcv2 e métodos de produção de tais composições
US7833707B2 (en)	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en)	2005-12-29	2010-04-20	Boehringer Ingelheim Vetmedica, Inc.	PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru)	2004-12-30	2011-08-25	Берингер Ингельхейм Ветмедика, Инк.	Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en)	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
CN1328373C (zh) *	2005-04-07	2007-07-25	南京农业大学	猪ⅱ型圆环病毒重组腺病毒
EP1896069B1 (fr) *	2005-06-24	2013-03-13	Intervet International BV	Vaccins chimères inactivés et leurs procédés d'utilisation
ES2425228T3 (es) *	2005-09-09	2013-10-14	Intervet International B.V.	Vacuna contra el PCV-2
EP3868400A1 (fr)	2005-12-29	2021-08-25	Boehringer Ingelheim Animal Health USA Inc.	Compositions immunogènes pcv2 multifonctionnelles et procédés de production de ces compositions
DK3766518T3 (da) *	2005-12-29	2026-04-13	Boehringer Ingelheim Animal Health Usa Inc	Immunogen pcv2-sammensætning til mindskelse af kliniske symptomer hos grise
JP4625485B2 (ja) *	2006-09-29	2011-02-02	財団法人大阪産業振興機構	高病原性トリインフルエンザウイルスに対するモノクローナル抗体
US20100136060A1 (en) *	2006-11-22	2010-06-03	Boehringer Ingelheim Vetmedica, Inc.	Methods of reducing porcine circovirus-associated disease outbreaks
EP2859900A1 (fr)	2006-12-11	2015-04-15	Boehringer Ingelheim Vetmedica, Inc.	Procédé efficace de traitement du circovirus porcin et des infections par lawsonia intracellularis
PT2094872T (pt) *	2006-12-15	2017-04-27	Boehringer Ingelheim Vetmedica Inc	Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2
EP1941903A1 (fr)	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxie et traitement du PRDC
EP1958644A1 (fr)	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prévention et traitement du PCVD subclinique
MX2009012793A (es) *	2007-05-30	2010-03-26	Wyeth Llc	Poxvirus de mapache que expresa genes de virus porcino.
US20090017064A1 (en) *	2007-07-10	2009-01-15	Wyeth	Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
US7829274B2 (en) *	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
EP2217271B1 (fr)	2007-11-06	2016-05-04	Zoetis Services LLC	Vaccin à virus vivant avirulent avec adjuvant contre mycoplasma hyopneumoniae
CL2008003813A1 (es) *	2007-12-21	2009-03-20	Zoetis W Llc	Circovirus porcino; molecula de acido nucleico que lo codifica; composicion inmunogenica que lo comprende; metodo para inmunizar un cerdo contra la infeccion virica o para prevenir el sindrome postdestete de desgaste multi-sistemico (pmsw);y metodo para determinar si un mamifero tiene o esta en riesgo de desarrollar pmsw.
CN101932336B (zh) *	2007-12-31	2014-07-09	贝林格尔.英格海姆维特梅迪卡有限公司	有外来氨基酸插入的pcv2 orf2病毒样颗粒
KR20100113582A (ko)	2008-01-23	2010-10-21	베링거잉겔하임베트메디카인코퍼레이티드	Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
EP2254595A4 (fr) *	2008-02-15	2012-12-05	Boehringer Ingelheim Vetmed	Procédés et compositions pour réduire l impact de maladies entériques
BRPI0911200A2 (pt) *	2008-04-16	2016-07-05	Virginia Tech Intelectual Properties Inc	circovírus suíno quimérico pcv2gen-1 rep e usos do mesmo
TWI627281B (zh)	2009-09-02	2018-06-21	百靈佳殷格翰家畜藥品公司	降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物
EP2547770B1 (fr)	2010-03-16	2019-11-27	Virginia Tech Intellectual Properties, Inc.	Vaccin contre le circovirus porcin chimère atténué à virus vivants
TWI508974B (zh)	2010-12-22	2015-11-21	Sbc Virbac Ltd	豬第二型環狀病毒(Porcine Circovirus Type 2)、含彼之免疫組合物、檢測套組及其應用
EP2660356A4 (fr)	2010-12-28	2014-07-09	Jx Nippon Oil & Energy Corp	Dispositif d'hydrogénation de composé organique et procédé d'hydrogénation
HUP1100470A2 (en) *	2011-08-30	2013-03-28	Mezoegazdasagi Biotechnologiai Kutatokoezpont	Nanoparticle-based veterinary vaccine
UA113192C2 (xx)	2011-12-06	2016-12-26		Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2)
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
UA114503C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA114504C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
KR102217387B1 (ko) *	2013-03-11	2021-02-19	주식회사 중앙백신연구소	재조합 효모 전세포(yeast whole cell)을 이용한 돼지 써코바이러스(PCV2) 서브유닛 백신과 그의 제조 방법
CN105579060B (zh)	2013-09-25	2021-03-16	硕腾服务有限责任公司	Pcv2b趋异株疫苗组合物以及使用方法
MX373884B (es)	2013-10-02	2020-03-26	Boehringer Ingelheim Animal Health Usa Inc	Variante de la proteína pcv2 orf2 y partículas similares al virus compuestas por ésta.
CN103602759B (zh) *	2013-11-22	2015-09-23	福建省农业科学院畜牧兽医研究所	一种区别鸭圆环病毒和鹅圆环病毒的pcr-rflp方法
CN105848675A (zh)	2013-12-03	2016-08-10	英特维特国际股份有限公司	抗猪圆环病毒2型的疫苗
EA201800494A1 (ru) *	2016-03-07	2019-07-31	Вирджиния Тех Интеллектуал Пропертис, Инк.	Вакцины против химерного цирковируса свиней типа 2 (pcv2)
CN106497892A (zh) *	2016-09-07	2017-03-15	扬州大学	带KT3标签的重组病毒rPCV2‑KT3的构建方法
MX420109B (es)	2018-03-26	2025-02-10	Boehringer Ingelheim Animal Health Usa Inc	Metodo para producir una composicion inmunogenica
CN112898435B (zh) *	2021-01-14	2023-03-31	山西农业大学	一种可溶性融合蛋白DT390-Cap及其制备方法与应用
KR20260005385A (ko)	2023-05-03	2026-01-09	베링거잉겔하임베트메디카게엠베하	면역 반응을 유도하는 방법
AR132581A1 (es)	2023-05-03	2025-07-16	Boehringer Ingelheim Vetmedica Gmbh	Composición inmunógena útil para la autoadministración por cerdos
US20250332243A1 (en)	2024-04-30	2025-10-30	Zoetis Services Llc	Methods of manufacturing porcine endogenous retrovirus (perv) free animal health vaccines
US20250332242A1 (en)	2024-04-30	2025-10-30	Zoetis Services Llc	Porcine endogenous retrovirus (perv)-free porcine circovirus type 2d-based vaccines and methods of use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6517843B1 (en)	1999-08-31	2003-02-11	Merial	Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2769321B1 (fr)	1997-10-03	2001-10-26	Merial Sas	Nouveaux circovirus porcins, vaccins et reactifs de diagnostics
FR2769322B1 (fr)	1997-10-03	2002-03-08	Merial Sas	Nouveaux circovirus porcins, vaccins et reactifs de diagnostic
UA78180C2 (uk)	1997-10-03	2007-03-15	Меріаль	Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
FR2781159B1 (fr)	1998-07-06	2000-10-06	Merial Sas	Vaccin circovirus et parvovirus porcin
US6391314B1 (en)	1997-10-03	2002-05-21	Merial	Porcine circoviruses vaccines diagnostic reagents
FR2772047B1 (fr)	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
DE69837934T2 (de) *	1997-12-11	2008-02-21	University Of Saskatchewan, Saskatoon	Multisystemisches kümmerwuchssyndrom durch viren in schweinen
EP1064024A4 (fr)	1998-03-13	2005-04-06	Univ Georgia Res Found	Vaccins contre les infections par circovirus
US6943152B1 (en)	1999-06-10	2005-09-13	Merial	DNA vaccine-PCV
US6497883B1 (en)	1999-06-10	2002-12-24	Merial	Porcine circovirus recombinant poxvirus vaccine
WO2001083737A2 (fr)	2000-05-03	2001-11-08	University Of Guelph	Vaccin d"adenovirus porcin
MXPA02011545A (es)	2000-05-24	2003-06-06	Merial Sas	Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela.
AU2001266940A1 (en)	2000-06-15	2001-12-24	Purdue Research Foundation	Vaccine for congenital tremors in pigs
DE10044648A1 (de)	2000-09-08	2002-03-21	Aventis Behring Gmbh	Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material
BRPI0208456B8 (pt)	2001-03-27	2021-05-25	Univ Saskatchewan	métodos para cultura de circovírus
AUPR567401A0 (en)	2001-06-14	2001-07-12	University Of Melbourne, The	Circovirus vaccines

2002
- 2002-12-09 US US10/314,512 patent/US7276353B2/en not_active Expired - Lifetime
- 2002-12-11 DK DK02797280.1T patent/DK1487483T3/da active
- 2002-12-11 DE DE60238278T patent/DE60238278D1/de not_active Expired - Lifetime
- 2002-12-11 SI SI200230932T patent/SI1487483T1/sl unknown
- 2002-12-11 WO PCT/US2002/039646 patent/WO2003049703A2/fr not_active Ceased
- 2002-12-11 ES ES02797280T patent/ES2355814T3/es not_active Expired - Lifetime
- 2002-12-11 PT PT02797280T patent/PT1487483E/pt unknown
- 2002-12-11 RS YUP-517/04A patent/RS51288B/sr unknown
- 2002-12-11 AT AT02797280T patent/ATE487490T1/de active
- 2002-12-11 EP EP10184702.8A patent/EP2264050B1/fr not_active Expired - Lifetime
- 2002-12-11 ES ES10184702.8T patent/ES2694505T3/es not_active Expired - Lifetime
- 2002-12-11 NZ NZ567688A patent/NZ567688A/en not_active IP Right Cessation
- 2002-12-11 NZ NZ533256A patent/NZ533256A/en not_active IP Right Cessation
- 2002-12-11 PT PT10184702T patent/PT2264050T/pt unknown
- 2002-12-11 DE DE201112100001 patent/DE122011100001I1/de active Pending
- 2002-12-11 CN CN201210306454.2A patent/CN103536911B/zh not_active Expired - Lifetime
- 2002-12-11 DK DK10184702.8T patent/DK2264050T3/en active
- 2002-12-11 DK DK10184612.9T patent/DK2263689T3/en active
- 2002-12-11 EP EP10184771A patent/EP2263690A3/fr not_active Withdrawn
- 2002-12-11 SI SI200231091T patent/SI2264050T1/sl unknown
- 2002-12-11 HR HRP20040626AA patent/HRP20040626B9/hr not_active IP Right Cessation
- 2002-12-11 CA CA2784260A patent/CA2784260C/fr not_active Expired - Lifetime
- 2002-12-11 LT LTEP10184702.8T patent/LT2264050T/lt unknown
- 2002-12-11 HU HU1600373A patent/HU231018B1/hu unknown
- 2002-12-11 AU AU2002362147A patent/AU2002362147C1/en not_active Expired
- 2002-12-11 HU HU1300097A patent/HU230576B1/hu unknown
- 2002-12-11 PL PL395510A patent/PL395510A1/pl not_active Application Discontinuation
- 2002-12-11 EP EP10184612.9A patent/EP2263689B1/fr not_active Expired - Lifetime
- 2002-12-11 SI SI200231053T patent/SI2263689T1/sl unknown
- 2002-12-11 CN CN02828049.0A patent/CN1620310B/zh not_active Expired - Lifetime
- 2002-12-11 BR BRPI0214919A patent/BRPI0214919B1/pt not_active IP Right Cessation
- 2002-12-11 PT PT101846129T patent/PT2263689E/pt unknown
- 2002-12-11 MX MXPA04005364A patent/MXPA04005364A/es active IP Right Grant
- 2002-12-11 HU HU1800263A patent/HU231162B1/hu active Protection Beyond IP Right Term
- 2002-12-11 HR HRP20140002AA patent/HRP20140002B1/hr not_active IP Right Cessation
- 2002-12-11 ME MEP-2008-177A patent/ME00126B/fr unknown
- 2002-12-11 HR HRP20140003AA patent/HRP20140003B1/hr not_active IP Right Cessation
- 2002-12-11 PL PL374382A patent/PL214803B1/pl not_active IP Right Cessation
- 2002-12-11 PL PL395509A patent/PL215058B1/pl unknown
- 2002-12-11 JP JP2003550754A patent/JP4623964B2/ja not_active Expired - Lifetime
- 2002-12-11 ES ES10184612.9T patent/ES2529726T3/es not_active Expired - Lifetime
- 2002-12-11 HU HU0501000A patent/HU228584B1/hu active Protection Beyond IP Right Term
- 2002-12-11 KR KR1020047009126A patent/KR101014544B1/ko not_active Expired - Lifetime
- 2002-12-11 EP EP18175133.0A patent/EP3388515A1/fr active Pending
- 2002-12-11 CA CA2469599A patent/CA2469599C/fr not_active Expired - Lifetime
- 2002-12-11 EP EP02797280A patent/EP1487483B1/fr not_active Expired - Lifetime
- 2002-12-12 TW TW091135955A patent/TWI314580B/zh not_active IP Right Cessation
2004
- 2004-06-10 CO CO04054666A patent/CO5590938A2/es unknown
2008
- 2008-05-27 AU AU2008202333A patent/AU2008202333B2/en not_active Expired
2011
- 2011-02-03 CY CY20111100127T patent/CY1111167T1/el unknown
- 2011-02-25 AU AU2011200843A patent/AU2011200843B2/en not_active Expired
- 2011-04-29 BE BE2011C008C patent/BE2011C008I2/fr unknown
- 2011-05-02 LU LU91814C patent/LU91814I2/fr unknown
- 2011-05-03 FR FR11C0014C patent/FR11C0014I2/fr active Active
- 2011-05-06 NL NL300480C patent/NL300480I2/nl unknown
- 2011-05-06 CY CY2011004C patent/CY2011004I2/el unknown
2018
- 2018-11-05 CY CY181101151T patent/CY1121112T1/el unknown
2021
- 2021-09-14 HU HUS2100036C patent/HUS2100036I1/hu unknown

Also Published As

Publication number	Publication date
BRPI0214919B1 (pt)	2015-09-15
HUS2100036I1 (hu)	2021-09-28
EP2264050B1 (fr)	2018-08-08
CO5590938A2 (es)	2005-12-30
KR20040086243A (ko)	2004-10-08
PT2264050T (pt)	2018-11-21
MEP17708A (bs)	2010-06-10
RS51288B (sr)	2010-12-31
EP1487483A4 (fr)	2006-02-15
WO2003049703A2 (fr)	2003-06-19
HUP1300097A2 (en)	2007-12-28
PL374382A1 (en)	2005-10-17
WO2003049703A3 (fr)	2004-09-30
DE122011100001I1 (de)	2011-09-08
HRP20140002B1 (hr)	2020-10-16
HRP20140002A2 (hr)	2014-11-07
US20030170270A1 (en)	2003-09-11
BR0214919A (pt)	2006-05-30
FR11C0014I1 (fr)	2011-06-17
HRP20140003A2 (hr)	2014-11-07
JP4623964B2 (ja)	2011-02-02
NZ533256A (en)	2008-06-30
EP2264050A2 (fr)	2010-12-22
CA2784260A1 (fr)	2003-06-19
PL215058B1 (pl)	2013-10-31
TW200307042A (en)	2003-12-01
CN103536911B (zh)	2019-09-13
AU2011200843B2 (en)	2012-01-19
BE2011C008I2 (fr)	2022-02-02
CN1620310A (zh)	2005-05-25
PL395509A1 (pl)	2011-12-19
LT2264050T (lt)	2018-11-26
CY2011004I2 (el)	2015-10-07
AU2002362147B2 (en)	2008-03-13
RS51704A (sr)	2006-10-27
CA2469599A1 (fr)	2003-06-19
PL395510A1 (pl)	2011-12-19
HRP20040626B1 (hr)	2016-08-26
CY2011004I1 (el)	2014-04-09
US7276353B2 (en)	2007-10-02
TWI314580B (en)	2009-09-11
HU231018B1 (hu)	2019-11-28
EP2263689B1 (fr)	2014-11-12
WO2003049703A8 (fr)	2005-12-01
EP3388515A1 (fr)	2018-10-17
NL300480I2 (fr)	2016-11-01
HU231162B1 (hu)	2021-05-28
CA2784260C (fr)	2016-05-17
EP1487483A2 (fr)	2004-12-22
JP2005511075A (ja)	2005-04-28
ATE487490T1 (de)	2010-11-15
ES2694505T3 (es)	2018-12-21
EP2263689A3 (fr)	2011-04-20
LU91814I2 (fr)	2011-07-04
KR101014544B1 (ko)	2011-02-16
DK1487483T3 (da)	2011-02-21
HUP0501000A2 (en)	2007-12-28
AU2002362147A1 (en)	2003-06-23
HK1151988A1 (en)	2012-02-17
CN103536911A (zh)	2014-01-29
HRP20140003B1 (hr)	2020-10-16
AU2008202333B2 (en)	2010-11-25
PT1487483E (pt)	2011-02-10
NZ567688A (en)	2009-09-25
MXPA04005364A (es)	2004-09-27
HU228584B1 (en)	2013-04-29
PL214803B1 (pl)	2013-09-30
DK2263689T3 (en)	2015-02-02
EP2263689A2 (fr)	2010-12-22
ES2355814T3 (es)	2011-03-31
AU2002362147C1 (en)	2012-05-17
SI1487483T1 (sl)	2011-03-31
ES2529726T3 (es)	2015-02-25
EP2263690A3 (fr)	2011-06-08
SI2264050T1 (sl)	2018-12-31
CN1620310B (zh)	2014-11-26
DK2264050T3 (en)	2018-12-03
HRP20040626B9 (hr)	2016-09-23
CY1111167T1 (el)	2014-04-09
PT2263689E (pt)	2015-02-13
CA2469599C (fr)	2012-10-23
DE60238278D1 (de)	2010-12-23
AU2011200843A1 (en)	2011-03-17
CY1121112T1 (el)	2019-12-11
HU230576B1 (hu)	2017-01-30
AU2008202333A1 (en)	2008-06-19
EP1487483B1 (fr)	2010-11-10
EP2263690A2 (fr)	2010-12-22
ME00126B (fr)	2010-10-10
HRP20040626A2 (en)	2006-03-31
SI2263689T1 (sl)	2015-03-31
EP2264050A3 (fr)	2011-04-20

Publication	Publication Date	Title
FR11C0014I2 (fr)	2022-03-11	Clones d'adn infectieux chimeres de circovirus porcin et utilisation de ceux-ci
IL150756A0 (en)	2003-02-12	Novel use of hiv proteins
DE60226535D1 (de)	2008-06-26	Entgiftung von "solid free form fabrication" Materialien
EP1418940A4 (fr)	2006-09-20	Vecteurs d'expression d'adn et procedes d'utilisation
MA27126A1 (fr)	2005-01-03	3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES
EP1383528A4 (fr)	2005-03-09	Sequences d'epitopes
ID30590A (id)	2002-01-03	Celana sekali pakai jenis-celana pendek
FR12C0012I2 (fr)	2012-10-26	Combinaisons d'herbicides et de phytoprotecteurs
EP1294378A4 (fr)	2004-01-28	Mimiques de thrombopoietine
DK0935660T3 (da)	2007-10-29	Infektiöse kloner af RNA-virusser og vacciner og deraf afledte diagnostiske assays
EP1727915A4 (fr)	2008-12-24	Clones d'adn infectieux chimeriques, circovirus porcins chimeriques et utilisations de ceux-ci
FI20012330L (fi)	2003-05-29	Piezosähköinen käyttöliittymä
EP1394232A4 (fr)	2006-05-31	Composition hydrophobe et oleophobe
EP1294513A4 (fr)	2005-11-23	Bioconjugaison covalente, de restriction, de proteines
DE60216254D1 (de)	2007-01-04	Acrylkautschukzusammensetzung und vulkanisat
ATE320242T1 (de)	2006-04-15	Medizinische aerosolzusammensetzung
DE60231764D1 (de)	2009-05-14	Bildaufzeichnungsmaterialien und Verfahren zu ihrer Herstellung
DE69802457D1 (de)	2001-12-20	Piezoelektrische keramische Zusammensetzung
EP1357940A4 (fr)	2004-03-17	Traitement du virus de l'hepatite b
DE50015096D1 (de)	2008-05-21	Das genom des hiv-1 intersubtyps (c/b') und seine anwendungen
DE60142051D1 (de)	2010-06-17	Herstellung von perfluorolefinen
FR2831732B1 (fr)	2004-01-16	Fourniture d'images numeriques geolocalisees personnalisees
ID29396A (id)	2001-08-30	Komposisi pengupasan dan pembersihan
EP1326625A4 (fr)	2005-05-04	Composition immunogene de l'hepatite c et procedes d'utilisation de cette derniere
DE60031108D1 (de)	2006-11-16	Verfahren zur Herstellung von Vinylamin-Vinylalkohol-Copolymeren und Verwendung davon